Luis Borges's Net Worth
$2.21 Million
Who is Luis Borges?
Luis Borges has an estimated net worth of $2.21 Million. This is based on reported shares across multiple companies, which include Century Therapeutics, Inc., and FIVE PRIME THERAPEUTICS INC.
SEC CIK
Luis Borges's CIK is 0001684015
Past Insider Trading and Trends
2023 was Luis Borges's most active year for acquiring shares with 8 total transactions. Luis Borges's most active month to acquire stocks was the month of January. 2023 was Luis Borges's most active year for disposing of shares, totalling 7 transactions. Luis Borges's most active month to dispose stocks was the month of February. 2023 saw Luis Borges paying a total of $368,426.88 for 663,946 shares, this is the most they've acquired in one year. In 2017 Luis Borges cashed out on 19,390 shares for a total of $873,092.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Century Therapeutics, Inc. (IPSC) Snapshot price: $4.55
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.99% | 7.45K |
$1.03 | $7,675.56 | 256.54K |
Apr 3
| |||
Form 4
| +469.33% | 205.33K |
$2.38 | -$179,128.16 | 249.08K |
Mar 21 - Mar 23
| |||
Form 4
|
∞
| 43.75K |
—
|
—
| 43.75K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS INC No price found
SVP, Research
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.80% | -18.08K |
$44.77 | -$809,620.68 | 64.89K |
Mar 1
| |||
Form 4
| +18.00% | 12.66K |
—
|
—
| 82.97K |
Feb 7
| |||
Form 4
| -1.82% | -1.31K |
$48.60 | -$63,471.60 | 70.32K |
Jan 3
| |||
Form 4
| +7.51% | 5K |
—
|
—
| 71.62K |
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Metagenomi, Inc. No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 69.32K |
—
|
—
| 69.32K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||